Researchers at Texas A&M University have created a nasal spray that reverses brain aging by reducing inflammation and restoring memory function within weeks. The therapy uses extracellular vesicles carrying microRNAs to bypass the blood-brain barrier and deliver treatment directly to brain tissue. Led by Dr. Ashok Shetty, the team demonstrated significant improvements in cognitive function across both genders in studies published in the Journal of Extracellular Vesicles.

The nasal spray works by suppressing inflammatory pathways like NLRP3 and cGAS-STING while recharging neuronal mitochondria, the cellular power plants responsible for brain energy. In behavioral tests, treated subjects showed marked improvements in object recognition and environmental adaptation compared to controls. This non-invasive delivery method eliminates the need for brain surgery or risky procedures, offering a practical alternative for widespread clinical use.

With dementia cases projected to double by 2060, this therapy addresses a critical public health challenge affecting millions. The treatment restored the brain's natural repair systems, effectively switching off chronic inflammation associated with aging. Scientists filed a U.S. patent for the approach, which could extend beyond aging to help stroke survivors and those with cognitive decline.

The research, backed by the National Institute on Aging, represents a shift from managing to potentially reversing brain aging. Rather than simply extending lifespan, this approach aims for successful brain aging that keeps people engaged and alert. The team's work demonstrates that the aging brain engine can be reignited, not just paused.